With the treatment of recombination human IL1B, we observed impairment of EMT phenotype, invasion, and proliferation in CD44s deficient cells were rescued, which suggested that CD44s deficiency-mediated IL1B decrease contributed to the inhibition of HCC progression. Here, IL1B is linked to hepatocellular carcinoma.